EATRIS appointed its new Scientific Advisory Board

Published 7 July 2019

 We are excited to announce that our new Scientific Advisory Board is formed. 

“This Board will bring the necessary expertise to provide guidance on the development of our strategies and activities. They will be the external advisory body for the Board of Governors, in particular, for aspects related to the scientific strategy of the organisation.

We are privileged to have onboard a group of high-profile experts that will enrich EATRIS life, a combination of experience and expertise along the entire translational science value chain.” as stated by Toni Andreu, EATRIS Scientific Director. 

 We would like to thank the former members of our Scientific Advisory Board, Josè Luis Jorcano Gerard Pasterkamp and Leo Schalkwyk, for their invaluable contribution towards the advancement of translational research. 

Nicole Déglon is an expert in gene therapy of neurodegenerative diseases. Currently based in Laussane. Active in EATRIS life with a clear commitment towards the organisation… See full profile

Hugo Van Heuverswyn is one of the pioneers in turning modern biotechnology into industrial applications in Belgium. Since 2017 he is preparing the creation of an international research consortium aiming at the validation and use of the pig as a model for translational preclinical R&D… See full profile


Peter Kocis is a drug development expert in combinatorial chemistry based in the US. Active in EATRIS life with a clear commitment towards the organisation…See full profile

Catherine Larue is punctually serving as an expert for the European Commission (H2020, IMI, PerMed programmes) and for the Luxembourg Plan Cancer…See full profile

Andres Metspalu is serving in several national and international committees, editorial boards and has received among other awards and honors the Order of the Estonian Red Cross 3rd Class and L’Ordre des Palmes Academiques from the Republic of France. From 2010 he was awarded Doctor Honoris Causa from Vilnius University…See full profile